Pharma-Bio Serv, Inc. financial data

Symbol
PBSV on OTC
Location
Dorado, PR
Fiscal year end
31 October
Latest financial report
17 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 628% % -7.3%
Debt-to-equity 18% % -20%
Return On Equity -0.66% % 82%
Return On Assets -0.56% % 82%
Operating Margin -7.2% % 26%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22,901,692 shares -0.13%
Common Stock, Shares, Outstanding 22,902,892 shares -0.24%
Entity Public Float $13,638,206 USD 0%
Common Stock, Value, Issued $2,352 USD 0%
Weighted Average Number of Shares Outstanding, Basic 22,905,743 shares -0.23%
Weighted Average Number of Shares Outstanding, Diluted 22,912,954 shares -0.21%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $8,824,729 USD -8.1%
Cost of Revenue $5,960,432 USD -13%
Operating Income (Loss) $640,006 USD 32%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $67,421 USD 86%
Income Tax Expense (Benefit) $8,718 USD -16%
Net Income (Loss) Attributable to Parent $76,139 USD 85%
Earnings Per Share, Diluted -0.01 USD/shares 67%

Balance Sheet

Label TTM Value / Value Unit Change %
Marketable Securities, Current $4,796,568 USD -6.5%
Accounts Receivable, after Allowance for Credit Loss, Current $2,654,675 USD -1%
Assets, Current $13,323,969 USD -14%
Property, Plant and Equipment, Net $103,674 USD -35%
Operating Lease, Right-of-Use Asset $0 USD -100%
Other Assets, Noncurrent $120,783 USD -46%
Assets $13,548,426 USD -16%
Liabilities, Current $3,309,695 USD -3.2%
Accrued Income Taxes, Noncurrent $0 USD
Operating Lease, Liability, Noncurrent $0 USD -100%
Liabilities $3,309,695 USD -19%
Accumulated Other Comprehensive Income (Loss), Net of Tax $280,358 USD 15%
Retained Earnings (Accumulated Deficit) $8,848,822 USD -17%
Stockholders' Equity Attributable to Parent $10,238,731 USD -15%
Liabilities and Equity $13,548,426 USD -16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $175,539 USD 90%
Net Cash Provided by (Used in) Financing Activities $1,753,042 USD -1.5%
Net Cash Provided by (Used in) Investing Activities $312,015 USD -93%
Common Stock, Shares Authorized 50,000,000 shares 0%
Common Stock, Shares, Issued 23,519,672 shares 0%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,543,505 USD -273%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5,763,618 USD -21%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Operating Lease, Liability $194,035 USD -44%
Payments to Acquire Property, Plant, and Equipment $9,055 USD -94%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $39,664 USD 92%
Lessee, Operating Lease, Liability, to be Paid $29,122 USD
Property, Plant and Equipment, Gross $315,988 USD -62%
Operating Lease, Liability, Current $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two $29,121 USD -83%
Lessee, Operating Lease, Liability, to be Paid, Year One $174,730 USD 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9,816 USD -69%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $1,688,166 USD 2%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%